Post-earnings recap
Reported
Thu, Oct 20, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Quest Diagnostics reported a better-than-expected EPS for the third quarter, which contributed to a positive stock reaction, with shares rising by 6.32%. The lack of revenue data and guidance leaves some uncertainty about future performance. Investors may view the EPS beat as a sign of resilience in the company's operations.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.36 | N/A | +9.61% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.